PMA device
Melody TPV System
Medtronic, Inc. · Pulmonary Valve Prosthesis Percutaneously Delivered (NPV, ) · First FDA decision Apr 18, 2019, newest Apr 18, 2019Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
5
Naming "Melody TPV"
MAUDE reports
0
Brand "Melody TPV", since 2015
PubMed studies
20
Mentioning "Melody TPV"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Melody TPV System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Melody TPV SystemPMA supplement
P140017-S014 · Decided Apr 18, 2019 · 156 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Melody TPV", any status and sponsor, newest update first.
Medtronic CardiovascularPublic (MDT)
NCT00740870 · 171 participants · Start Jan 2007 · Primary completion May 2015
Device: Transcatheter Pulmonary Valve replacement · For: Congenital Heart Defects; Dysfunctional Right Ventricular Outflow Tract Conduits
Sites: Miami, Florida; Boston, Massachusetts; New York, New York · 5 sites in all
- Melody PB1016 Surveillance StudyCompleted
Medtronic Heart ValvesPublic (MDT)
NCT02347189 · 39 participants · Start Nov 2014 · Primary completion Nov 2016
Device: Melody Transcatheter Pulmonary Valve PB1016 · For: Dysfunctional RVOT Conduits in Patients With Congenital Heart Defects
Sites: Los Angeles, California; Detroit, Michigan; Columbus, Ohio · 8 sites in all
Medtronic CardiovascularPublic (MDT)
NCT01186692 · 131 participants · Start Jul 2010 · Primary completion Jan 2013
Device: Melody® Transcatheter Pulmonary Valve · For: Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit
Sites: San Diego, California; Oak Lawn, Illinois; Ann Arbor, Michigan · 10 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Melody TPV", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NPV
2,196 reports: 375 malfunction, 1,749 injury, 72 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Melody TPV"[tiab]. The summary above synthesizes these.
- Fifteen years of experience with the melodyࡊ TPV for percutaneous pulmonary valve replacement.
Bjorn C, De Meester P, Budts W, et al. · Acta Cardiol · 2025Observational Study
- Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
Zablah JE, Døhlen G, Ystgaard MB, et al. · Catheter Cardiovasc Interv · 2022
- Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.
Jones TK, McElhinney DB, Vincent JA, et al. · Circ Cardiovasc Interv · 2022Clinical Trial, Research Support, Non-U.S. Gov't
- Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience.
Davtyan A, Guyon PW, El-Sabrout HR, et al. · Pediatr Cardiol · 2022Multicenter Study
- The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement.
McElhinney DB, Hennesen JT · Ann N Y Acad Sci · 2013Review
- Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.
Benson LN, Gillespie MJ, Bergersen L, et al. · Circ Cardiovasc Interv · 2020Multicenter Study
- Acute Leaflet Dysfunction in Transcatheter Pulmonary Valves.
Qadir A, Van Lente L, Al-Khatib Y, et al. · JACC Case Rep · 2026Case Reports
- Early multicenter experience of Melody valve implantation in India.
Sheth K, Azad S, Dalvi B, et al. · Ann Pediatr Cardiol · 2021
- Leaflet morphology classification of the Melody Transcatheter Pulmonary Valve.
Boe BA, Cheatham SL, Armstrong AK, et al. · Congenit Heart Dis · 2019
- Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure.
Gillespie MJ, McElhinney DB, Kreutzer J, et al. · Ann Thorac Surg · 2015Research Support, Non-U.S. Gov't
- Early Outcomes and Mid-Term Follow-Up of Melody TPV Implantation: A Ten-Year Single-Center Retrospective Observational Study.
Giordano M, Gaio G, Marzullo R, et al. · Healthcare (Basel) · 2026
- Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.
Markham R, Challa A, Kyranis S, et al. · Heart Lung Circ · 2017Observational Study
Other devices of this type
Also filed under product code NPV.
- SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive PrestentEdwards Lifesciences, LLC · PMA 2026
- Harmony TPV SystemMedtronic, Inc. · PMA 2026
- Edwards Commander Delivery SystemEdwards Lifesciences, LLC · PMA 2023
- Melody Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2017
- Edwards Alterra Adaptive Prestent SystemEdwards Lifesciences, LLC · PMA 2022
- Harmony Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2022
- 9600CR CrimperEdwards Lifesciences, LLC · PMA 2022
- Ensemble II Transcatheter Valve Delivery SystemMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.